HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kuan-Lin Kuo Selected Research

2,6-diaminopyridine-3,5-bis(thiocyanate)

10/2021PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kuan-Lin Kuo Research Topics

Disease

14Neoplasms (Cancer)
01/2021 - 01/2011
12Carcinoma (Carcinomatosis)
10/2021 - 01/2012
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 11/2015
2Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 11/2019
2Chondrosarcoma
12/2018 - 01/2017
1Lymphoma (Lymphomas)
06/2019
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
05/2016
1Paraganglioma (Paragangliomas)
01/2011
1Carcinogenesis
04/2010
1Microsatellite Instability
04/2010
1Chromosome Aberrations (Chromosome Abnormalities)
04/2010
1Genomic Instability
04/2010
1Sepsis (Septicemia)
11/2008
1Gram-Negative Bacterial Infections
11/2008

Drug/Important Bio-Agent (IBA)

6Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2015
4Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2020 - 01/2015
4pevonedistatIBA
01/2020 - 01/2015
3EnzymesIBA
10/2021 - 01/2015
3Histone Deacetylase InhibitorsIBA
03/2019 - 12/2018
3trichostatin A (A 300)IBA
03/2019 - 12/2018
2GemcitabineFDA Link
01/2021 - 12/2018
2Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2021 - 11/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 11/2019
2theasinensin AIBA
03/2019 - 12/2018
2Caspase 3 (Caspase-3)IBA
12/2018 - 01/2017
2Proteins (Proteins, Gene)FDA Link
12/2018 - 01/2012
2Celecoxib (Celebrex)FDA Link
01/2013 - 01/2012
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2013 - 01/2012
12,6-diaminopyridine-3,5-bis(thiocyanate)IBA
10/2021
1Therapeutic UsesIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Cullin Proteins (Cullins)IBA
01/2020
1temsirolimusFDA Link
01/2020
1Ligases (Synthetase)IBA
01/2020
1Trifluoperazine (Stelazine)FDA LinkGeneric
06/2019
1Complement Factor B (Factor B)IBA
06/2019
1Antipsychotic Agents (Antipsychotics)IBA
06/2019
1Paclitaxel (Taxol)FDA LinkGeneric
03/2019
1Caspase 7IBA
12/2018
1Anti-Bacterial Agents (Antibiotics)IBA
12/2018
1Histone Deacetylases (Histone Deacetylase)IBA
12/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2018
1ResveratrolIBA
01/2017
1Sirtuin 1IBA
01/2017
1SirtuinsIBA
01/2017
1entinostat (MS 275)IBA
01/2017
1TeaIBA
05/2016
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
05/2016
1JNK Mitogen-Activated Protein KinasesIBA
11/2015
1Mercaptoethanol (2 Mercaptoethanol)IBA
01/2013
12-MethoxyestradiolIBA
01/2013
1Arsenic Trioxide (Trisenox)FDA Link
01/2013
1Glucose (Dextrose)FDA LinkGeneric
01/2012
1AntibodiesIBA
01/2011
1StathminIBA
01/2011
1Indicators and Reagents (Reagents)IBA
04/2010
1Deoxyribonucleases (DNase)FDA Link
04/2010
1Protective AgentsIBA
11/2008

Therapy/Procedure

7Drug Therapy (Chemotherapy)
10/2021 - 11/2015
1Therapeutics
12/2018